Oman’s first pharmaceutical unit identifies key markets for exports

Oman’s first pharmaceutical unit identifies key markets for exports

Muscat: In a big boost for Oman’s pharmaceutical industry, Opal Bio Pharma, which organised the ground-breaking ceremony of its vaccine factory recently, has identified India, Pakistan, Bangladesh, Iran and other countries as potential markets to export its products. Speaking to Times of Oman’s sisterly radio channel Al Shabiba, Saad bin Musa Al-Junaibi, Chairman of the Board of Directors of Opal Bio Pharma Company, said: “The drug and vaccine factory under construction in Khazaen Economic City (KEC) will target the local market as well as the Gulf market, Republic of Yemen, in addition to East Africa, Iran, Pakistan, India and Bangladesh.” “The importance of the factory can be understood from the fact that it is the first-of-its-kind in the Sultanate of Oman as well as in the region to produce the latest vaccines which will contribute to achieving our goal of ‘Made in Oman’ to the world,” he added. Al Junaibi confirmed that the factory will aim to produce four different types of vaccines. It includes vaccines for colds, leukaemia and other types, all of which will be available in Oman at competitive prices or at a price much lower than the price in the foreign markets. Shortage of medicines Regarding